Identification of reduced circulating haptoglobin concentration as a biomarker of the severity of pulmonary embolism: a nontargeted proteomic study.
Risk stratification of patients with pulmonary embolism (PE) may identify patients at high risk of early death who may benefit from more intensive surveillance or aggressive therapy. Nontargeted proteomics may identify biomarkers useful for the risk stratification of patients with acute symptomatic...
Guardado en:
Autores principales: | María Insenser, Rafael Montes-Nieto, M Ángeles Martínez-García, Elena Fernandez Durán, Carmen Santiuste, Vicente Gómez, Jeffrey A Kline, Héctor F Escobar-Morreale, David Jiménez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3b7bc2520dca4a0e922da4fc89948213 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women.
por: Francisco Alvarez-Blasco, et al.
Publicado: (2009) -
Author Correction: Circulating Haptoglobin and Metabolic Syndrome in Renal Transplant Recipients
por: Isidor Minović, et al.
Publicado: (2018) -
Pulmonary migration of liquid embolization material: An unusual cause of pulmonary embolism
por: James Yeomans, MBChB, et al.
Publicado: (2022) -
Clinical variables that increase the probability of pulmonary embolism diagnosis in symptomatic children
por: Kara E. Hennelly, et al.
Publicado: (2020) -
Pulmonary embolism with chronic obstructive pulmonary disease
por: Ruohan Yang, et al.
Publicado: (2021)